Circulating tumor DNA–based detection of molecular residual disease as a biomarker for recurrence monitoring predict disease recurrence in patients with ovarian cancer. Phase 1/2 study of ARTS-021, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results